Oppenheimer Asset Management’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-14,614	Closed	-$92K	–	1262
2021 Q3	$92K	Sell	14,614 -298	-2%	-$1.84K	﹤0.01%	1180
2021 Q2	$89K	Sell	14,912 -163	-1%	-$968	﹤0.01%	1192
2021 Q1	$95K	Sell	15,075 -432	-3%	-$3.04K	﹤0.01%	1145
2020 Q4	$87K	Sell	15,507 -253	-2%	-$1.53K	﹤0.01%	1117
2020 Q3	$92K	Sell	15,760 -520	-3%	-$3.58K	﹤0.01%	1068
2020 Q2	$117K	Buy	16,280 +273	+2%	+$1.81K	﹤0.01%	1039
2020 Q1	$75K	Sell	16,007 -288	-2%	-$1.77K	﹤0.01%	1176
2019 Q4	$131K	Sell	16,295 -412	-2%	-$3K	﹤0.01%	1151
2019 Q3	$115K	Sell	16,707 -278	-2%	-$2.06K	﹤0.01%	1157
2019 Q2	$141K	Sell	16,985 -2,684	-14%	-$22.9K	﹤0.01%	1140
2019 Q1	$196K	Sell	19,669 -6,958	-26%	-$58.2K	﹤0.01%	1044
2018 Q4	$204K	Buy	+26,627	New	+$318K	0.01%	1000